Patents by Inventor Burkhard Mielke

Burkhard Mielke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS CONTAINING AN INSECTICIDE
    Publication number: 20020136748
    Abstract: The invention relates to insecticidal formulations based on polymers, to processes for their preparation and to their use for controlling insects encountered indoors. These novel formulations are characterized in that they contain at least one type of insecticide which is incorporated into an appropriate polymer. The formulations are capable of emitting the insecticide at a certain temperature in a controlled manner without changing their form and macroscopic appearance.
    Type: Application
    Filed: December 17, 1999
    Publication date: September 26, 2002
    Inventors: MIKE-DIRK BUBLITZ, RALF DUJARDIN, BURKHARD MIELKE, DIETMAR KISTERS
  • Gel formulations containing insecticide
    Patent number: 6447795
    Abstract: The present invention relates to novel insecticidal gel formulations for the controlled and sustained release of insecticidally active compounds by means of a heat source.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: September 10, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dietmar Kalder, Rolf Jung, Burkhard Mielke
  • GEL FORMULATIONS CONTAINING INSECTICIDE
    Publication number: 20010055604
    Abstract: The present invention relates to novel insecticidal gel formulations for the controlled and sustained release of insecticidally active compounds by means of a heat source.
    Type: Application
    Filed: January 14, 2000
    Publication date: December 27, 2001
    Inventors: DIETMAR KALDER, ROLF JUNG, BURKHARD MIELKE
  • Insecticide formulations
    Patent number: 6171608
    Abstract: The present invention relates to novel liquid formulations for the controlled and sustained release of insecticidally active compounds by means of a heat source and the water-based pre-solutions required for preparing these formulations.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: January 9, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Guido Schmitt, Gerd Schmitz, Klaus Walz, Burkhard Mielke, Hermann Neumann
  • Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars
    Patent number: 6034055
    Abstract: The present invention relates to (2-aminoacylamino-2-deoxy-glycosyl)-amides, which are substituted on the nitrogen atom of the amino acid, of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation and to their use in medicaments.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: March 7, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Oswald Lockhoff, Burkhard Mielke, Helmut Brunner, Klaus Schaller
  • 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives
    Patent number: 6018054
    Abstract: The invention relates to intermediate compounds for preparing novel quinolone derivatives- and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, to processes for their preparation and to antibacterial agents and feed additives containing them.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: January 25, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Philipps, Stephan Bartel, Andreas Krebs, Uwe Petersen, Thomas Schenke, Klaus-Dieter Bremm, Rainer Endermann, Karl Georg Metzger, Burkhard Mielke
  • Nucleic acid-binding oligomers for therapy and diagnosis
    Patent number: 5955571
    Abstract: The present invention relates to compounds of the general formula (I), ##STR1## in which the radicals have the meaning given in the description, to processes for their preparation and to their use as medicaments.
    Type: Grant
    Filed: August 1, 1995
    Date of Patent: September 21, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Christoph Schwemler, Thorsten Potter, Burkhard Mielke, Eckhard Schwenner, Axel Kretschmer, Udo Stropp, Winfried Kosch, Hansjorg Durr
  • Glycosylamides of 2-aminoacylamino-2-deoxy sugars
    Patent number: 5905071
    Abstract: The present invention relates to (2-aminoacylamino-2-deoxy-glycosyl)-amides, which are substituted on the nitrogen atom of the amino acid, of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation and to their use in medicaments.
    Type: Grant
    Filed: June 25, 1996
    Date of Patent: May 18, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Oswald Lockhoff, Burkhard Mielke, Helmut Brunner, Klaus Schaller
  • Pyrido?3,2,1-I,J!?3,1!benzoxazine derivatives
    Patent number: 5854241
    Abstract: Disclosed are pyrido?3,2,1-i,j!?3,1!benzoxazine compounds of the formula (I): ##STR1## wherein z represents a radical having the formula: ##STR2## wherein B represents --CH.sub.2 --, --O-- or a direct bond; and the other variables in formula (I) and Z are as described herein. The compounds have antibacterial properties and also disclosed are antibacterial compositions containing them and methods of using them to prevent or combat bacterial infections. Methods for preparing the compounds are also disclosed.
    Type: Grant
    Filed: January 3, 1997
    Date of Patent: December 29, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Werner Hallenbach, Thomas Himmler, Thomas Jaetsch, Burkhard Mielke, Klaus Dieter Bremm, Rainer Endermann, Franz Pirro, Michael Stegemann, Heinz-Georg Wetzstein
  • Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics
    Patent number: 5849893
    Abstract: The invention relates to nucleic acid-binding oligomers possessing C-branching of the general formula (I) ##STR1## and to the corresponding monomers, whose radicals have the meaning given in the description, and to their use as medicaments or diagnostic aids.
    Type: Grant
    Filed: September 24, 1996
    Date of Patent: December 15, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Antonius Lobberding, Burkhard Mielke, Christoph Schwemler, Eckhard Schwenner, Udo Stropp, Wolfgang Springer, Axel Kretschmer, Thorsten Potter
  • 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives
    Patent number: 5739339
    Abstract: The invention relates to novel quinolone derivatives and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, to processes for their preparation and to antibacterial agents and feed additives containing them.
    Type: Grant
    Filed: May 17, 1996
    Date of Patent: April 14, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Philipps, Stephan Bartel, Andreas Krebs, Uwe Petersen, Thomas Schenke, Klaus-Dieter Bremm, Rainer Endermann, Karl Georg Metzger, Burkhard Mielke
  • 8-amino-10-(azabicycloalkyl)-pyrido?1,2,3-d,e!?1,3,4!benzoxadiazine derivatives
    Patent number: 5679675
    Abstract: The present invention relates to new 8-amino-10-(azabicycloalkyl)-pyrido?1,2,3-d,e!?1,3,4!benzoxadiazine derivatives of the general formula (I) ##STR1## in which the radicals R.sup.1 to R.sup.4, Z and X.sup.1 have the meaning given in the description, processes for their preparation and their use in antibacterial compositions.
    Type: Grant
    Filed: May 4, 1995
    Date of Patent: October 21, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Jaetsch, Burkhard Mielke, Uwe Petersen, Thomas Schenke, Klaus-Dieter Bremm, Rainer Endermann, Karl-Georg Metzger, Martin Scheer, Michael Stegemann, Heinz-Georg Wetzstein
  • Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics
    Patent number: 5623049
    Abstract: The invention relates to nucleic acid-binding oligomers possessing N-branching of the general formula (I), ##STR1## and their monomers, where the individual radicals have the meaning given in the description, and to their use as medicaments or as aids in diagnostics.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: April 22, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Antonius L obberding, Burkhard Mielke, Christoph Schwemler, Eckhard Schwenner, Udo Stropp, Wolfgang Springer, Axel Kretschmer, Thorsten P otter
  • 1,9-bridged thiazolo[3,2-a]quinoline derivatives
    Patent number: 5618815
    Abstract: The present invention relates to 1,9-bridged thiazolo[3,2-a]quinoline derivatives of the general formula (I) ##STR1## in which the substituents Z, X, R.sup.1 have the meaning given in the description, to processes for their preparation and to their use in antibacterial compositions.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: April 8, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Jaetsch, Werner Hallenbach, Thomas Himmler, Burkhard Mielke, Klaus D. Bremm, Rainer Endermann, Franz Pirro, Michael Stegemann, Heinz-Georg Wetzstein
  • HIV antisense expression vectors
    Patent number: 5583035
    Abstract: The present invention relates to the targeted blocking of the genetic information of the viral messenger ribonucleic acid (mRNA) for virus replication (e.g. of HIV) in transfected, haematopoietic cells with particularly suitable expression systems, which express a complementary "antisense RNA".
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: December 10, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Axel Kretschmer, Horst-Peter Antonicek, Jorg Baumgarten, Antonius Loebberding, Burkhard Mielke, Wolfgang Springer, Udo Stropp, Mark-Michael Struck, Lothar Biesert, Helga Rubsamen-Waigmann, Hary Suhartono, Thomas-Peter Hausner
  • 7-isoindolinyl-naphthyridone derivatives, compositions and anti-bacterial use thereof
    Patent number: 5556979
    Abstract: The invention relates to novel quinolone derivatives and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, to processes for their preparation and to antibacterial agents and feed additives containing them.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: September 17, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Philipps, Stephan Bartel, Andreas Krebs, Uwe Petersen, Thomas Schenke, Klaus-Dieter Bremm, Rainer Endermann, Karl G. Metzger, Burkhard Mielke
  • Pyrido[1,2,3-D,E] [1,3,4]benzoxadiazine derivatives
    Patent number: 5508278
    Abstract: Novel bactericidal pyrido[1,2,3-d,e,][1,3,4]benzoxadiazine derivatives of the formula (I) ##STR1## in which R.sup.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl or halogen,R.sup.2 independently of R.sup.1 is hydrogen or methyl,R.sup.3 is hydrogen or C.sub.1 -C.sub.4 -alkyl,R.sup.4 is hydrogen, C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)-methyl,X.sup.
    Type: Grant
    Filed: August 26, 1994
    Date of Patent: April 16, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Thomas Jaetsch, Burkhard Mielke, Uwe Petersen, Thomas Philipps, Thomas Schenke, Klaus D. Bremm, Rainer Endermann, Karl G. Metzger, Martin Scheer, Michael Stegemann, Heinz-Georg Wetzstein
  • Oligophosphates with an antiviral action
    Patent number: 5169842
    Abstract: Novel oligophosphates with an antiviral action of the formula ##STR1## in which n is 3-50,B and E are, independently of one another, O, S or NH,A is O, NR or S,D is O, S or NR.sub.2, in which independently each R is H, alkyl, aralkyl or aryl,andX is --(CH.sub.2).sub.
    Type: Grant
    Filed: May 9, 1991
    Date of Patent: December 8, 1992
    Assignee: Bayer Aktiengesellschaft
    Inventors: Antonius Lobberding, Axel C. Heitmann, Burkhard Mielke, Udo Stropp, Axel Kretschmer, Helga Rubsamen-Waigmann, Lothar Biesert, Haryadi Suhartono